Smith & Nephew (NYSE:SNN) shareholders are concerned about the medical device maker's performance and may push for a breakup. The holders want CEO Deepak Nath to improve the company's fortunes or ...

Investors urge orthopaedics division spin-off -FT Smith&Nephew says operational fixes, sharper execution in place Shares flat in early trade Nov 14 (Reuters) - Smith & Nephew (SN.L), opens new tab ...

Smith & Nephew's Q3 results led to a 13% share price drop due to reduced FY24 guidance, mainly from lower demand in China. Despite short-term challenges, long-term fundamentals remain strong ...

Smith & Newphew is one of the world’s largest hip replacement manufacturers. Three of Smith & Nephew’s biggest shareholders are reportedly urging the FTSE 100 firm to break up if it cannot ...

Smith & Nephew’s chairman has defended its strategy as pressure from major investors calling for a break-up of the company intensified. Rupert Soames’s stand comes after The Mail on Sunday ...

Learn more about whether Smith & Nephew plc (ADR) is a good stock to buy or sell based on recent news as well as its key financial metrics. Read on to find out how (SNN) grades on certain investment ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

We believe the UK small-cap market offers a myriad of opportunities across a wide range of different businesses and industries.

WASHINGTON — Special counsel Jack Smith and his team plan to resign before President-elect Donald Trump takes office, a source familiar with the matter said. Smith’s office has been evaluating ...

Smith & Nephew is facing calls to break the company up as investors grow frustrated with its turnaround plan. The medical equipment giant's shareholders have put chief executive Deepak Nath on ...

Medical equipment company Smith & Nephew has agreed a $660 million deal to buy US biotech Osiris Therapeutics that expands its business into regenerative medicine. Osiris makes medical products ...